Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 19226202)

1.

Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"?

Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, Chong TW, Popovsky KA, Pruett TL, Sawyer RG.

Surg Infect (Larchmt). 2009 Feb;10(1):29-39. doi: 10.1089/sur.2007.041.

2.

Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.

Tellado JM, Wilson SE.

Surg Infect (Larchmt). 2005 Fall;6(3):329-43. Review.

PMID:
16201943
3.

Antimicrobial treatment for intra-abdominal infections.

Mazuski JE.

Expert Opin Pharmacother. 2007 Dec;8(17):2933-45. Review.

PMID:
18001254
4.

[Complicated intra-abdominal infections: pathogens, resistance. Recommendations of the Infectliga on antbiotic therapy].

Bodmann KF; und die Expertenkommission der Infektliga.

Chirurg. 2010 Jan;81(1):38-49. doi: 10.1007/s00104-009-1822-9. Review. German.

PMID:
20020092
5.

[Selection and use of anti-infective agents for intra-abdominal infections].

Coelho JC, Baretta GA, Okawa L.

Arq Gastroenterol. 2007 Jan-Mar;44(1):85-90. Review. Portuguese.

6.

Emerging infections in burns.

Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN.

Surg Infect (Larchmt). 2009 Oct;10(5):389-97. doi: 10.1089/sur.2009.024. Review.

7.

Overview of resistant gram-positive pathogens in the surgical patient.

Rapp RP.

Surg Infect (Larchmt). 2000;1(1):39-47. Review.

PMID:
12594908
8.

Critical issues in the clinical management of complicated intra-abdominal infections.

Blot S, De Waele JJ.

Drugs. 2005;65(12):1611-20. Review.

PMID:
16060697
9.

The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.

Powell LL, Wilson SE.

Surg Infect (Larchmt). 2000;1(1):57-63. Review.

PMID:
12594910
10.

The implications of enterococci for the intensive care unit.

Chatterjee I, Iredell JR, Woods M, Lipman J.

Crit Care Resusc. 2007 Mar;9(1):69-75. Review.

PMID:
17352670
11.

Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?

CaĆ­nzos M.

Clin Microbiol Infect. 2008 Dec;14 Suppl 6:9-18. doi: 10.1111/j.1469-0691.2008.02123.x. Review.

12.

Resistance patterns among nosocomial pathogens: trends over the past few years.

Jones RN.

Chest. 2001 Feb;119(2 Suppl):397S-404S. Review.

PMID:
11171776
14.

In vitro activity of ertapenem: review of recent studies.

Wexler HM.

J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. Review.

15.

[Etiology, epidemiology and microbiological diagnosis of intra-abdominal infections].

Nicoletti G, Nicolosi D, Rossolini GM, Stefani S.

Infez Med. 2008 Feb;16 Suppl 1:8-18. Review. Italian.

16.

Optimizing therapy for vancomycin-resistant enterococci (VRE).

Linden PK.

Semin Respir Crit Care Med. 2007 Dec;28(6):632-45. Review.

PMID:
18095227
17.

Beyond the target pathogen: ecological effects of the hospital formulary.

Goldstein EJ.

Curr Opin Infect Dis. 2011 Feb;24 Suppl 1:S21-31. doi: 10.1097/01.qco.0000393485.17894.4c. Review.

PMID:
21200181
18.
19.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
20.

Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.

Mazuski JE.

Surg Infect (Larchmt). 2005;6 Suppl 2:S-49-69. Review.

PMID:
23577497
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk